Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;21(8):1012-1021.
doi: 10.1002/ejhf.1503. Epub 2019 Jun 7.

Pharmacy-based Interdisciplinary Intervention for Patients With Chronic Heart Failure: Results of the PHARM-CHF Randomized Controlled Trial

Collaborators, Affiliations

Pharmacy-based Interdisciplinary Intervention for Patients With Chronic Heart Failure: Results of the PHARM-CHF Randomized Controlled Trial

Martin Schulz et al. Eur J Heart Fail. .

Abstract

Aims: Medication non-adherence is frequent and is associated with high morbidity and mortality in patients with chronic heart failure (CHF). We investigated whether an interdisciplinary intervention improves adherence in elderly CHF patients.

Methods and results: The study population (mean age 74 years, 62% male, mean left ventricular ejection fraction 47%, 52% in New York Heart Association class III) consisted of 110 patients randomized into the pharmacy care and 127 into the usual care group. The median follow-up was 2.0 years (interquartile range 1.2-2.7). The pharmacy care group received a medication review followed by regular dose dispensing and counselling. Control patients received usual care. The primary endpoint was medication adherence as proportion of days covered (PDC) within 365 days for three classes of heart failure medications (beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and mineralocorticoid receptor antagonists). The main secondary outcome was the proportion of adherent patients (PDC ≥ 80%). The primary safety endpoint was days lost due to unplanned cardiovascular hospitalizations (blindly adjudicated) or death. Pharmacy care compared with usual care resulted in an absolute increase in mean adherence to three heart failure medications for 365 days [adjusted difference 5.7%, 95% confidence interval (CI) 1.6-9.8, P = 0.007]. The proportion of patients classified as adherent increased (odds ratio 2.9, 95% CI 1.4-5.9, P = 0.005). Pharmacy care improved quality of life after 2 years (adjusted difference in Minnesota Living with Heart Failure Questionnaire scores -7.8 points (-14.5 to -1.1; P = 0.02), compared to usual care. Pharmacy care did not affect the safety endpoints of hospitalizations or deaths.

Conclusion: Pharmacy care safely improved adherence to heart failure medications and quality of life.

Keywords: Chronic heart failure; Community pharmacy services; Interdisciplinary care; Medication adherence; Pharmacy care; Randomized controlled trial.

Similar articles

See all similar articles

Cited by 1 article

  • The year in cardiology: heart failure.
    Cleland JGF, Lyon AR, McDonagh T, McMurray JJV. Cleland JGF, et al. Eur Heart J. 2020 Mar 21;41(12):1232-1248. doi: 10.1093/eurheartj/ehz949. Eur Heart J. 2020. PMID: 31901936

Publication types

LinkOut - more resources

Feedback